TrialJournal of gastrointestinal cancer2015

Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).

György Bodoky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.